Daly City, CA, United States of America

Alan Casilla

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Roche Molecular Systems, Inc.. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Casilla: Innovator in Nucleic Acid Capture Technology

Introduction

Alan Casilla is a notable inventor based in Daly City, California. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid capture technology. His innovative work has implications for various applications in diagnostics and research.

Latest Patents

Alan Casilla holds a patent for the "Successive capture of nucleic acid by magnetic glass particles." This patent outlines methods and components for effectively capturing nucleic acids using magnetic glass particles. His invention represents a significant advancement in the efficiency and effectiveness of nucleic acid capture processes.

Career Highlights

Throughout his career, Alan has worked with prominent companies in the biotechnology sector. He has been associated with Roche Molecular Systems, Inc. and Roche Diagnostics GmbH, where he contributed to various projects that leverage his expertise in molecular biology and diagnostics.

Collaborations

Alan has collaborated with talented professionals in his field, including Cherie Holcomb and Trevor Hryce. These collaborations have further enriched his work and contributed to advancements in nucleic acid technologies.

Conclusion

Alan Casilla is a distinguished inventor whose work in nucleic acid capture technology has made a lasting impact in the field of molecular biology. His innovative patent and career achievements highlight his commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…